Axel Meye

4.0k total citations
122 papers, 3.2k citations indexed

About

Axel Meye is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Axel Meye has authored 122 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 49 papers in Pulmonary and Respiratory Medicine and 44 papers in Oncology. Recurrent topics in Axel Meye's work include Sarcoma Diagnosis and Treatment (28 papers), Cancer-related Molecular Pathways (24 papers) and RNA Interference and Gene Delivery (18 papers). Axel Meye is often cited by papers focused on Sarcoma Diagnosis and Treatment (28 papers), Cancer-related Molecular Pathways (24 papers) and RNA Interference and Gene Delivery (18 papers). Axel Meye collaborates with scholars based in Germany, United States and Netherlands. Axel Meye's co-authors include Helge Täubert, Manfred P. Wirth, Susanne Fuessel, Peter Würl, Matthias Bache, U. Schmidt, Hannelore Schmidt, Matthias Kotzsch, Frank Bartel and Kai Kraemer and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Oncogene.

In The Last Decade

Axel Meye

121 papers receiving 3.1k citations

Peers

Countries citing papers authored by Axel Meye

Since Specialization

Citations

This map shows the geographic impact of Axel Meye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Meye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Meye more than expected).

Fields of papers citing papers by Axel Meye

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Axel Meye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Meye. The network helps show where Axel Meye may publish in the future.

Co-authorship network of co-authors of Axel Meye

This figure shows the co-authorship network connecting the top 25 collaborators of Axel Meye. A scholar is included among the top collaborators of Axel Meye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Axel Meye. Axel Meye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Serotonin and Melatonin Do Not Play a Prominent Role in the Growth of Prostate Cancer Cell Lines 2010 ·Urologia Internationalis ·(unknown), Axel Meye, Oliver W. Hakenberg, Susanne Fuessel, Manfred P. Wirth	18
2	Telomerase Inhibition by Synthetic Nucleic Acids and Chemosensitization in Human Bladder Cancer Cell Lines 2007 ·Methods in molecular biology ·Kai Kraemer, Susanne Fuessel, Axel Meye	5
3	Urokinase receptor splice variant uPAR-del4/5-associated gene expression in breast cancer: identification of rab31 as an independent prognostic factor 2007 ·Breast Cancer Research and Treatment ·Matthias Kotzsch, Anieta M. Sieuwerts, Marianne Großer, Axel Meye, Susanne Fuessel, Marion E. Meijer‐van Gelder, Marcel Smid, Manfred Schmitt, Gustavo Baretton, Thomas Luther, Viktor Magdolen, John A. Foekens	47
4	Synthetic Nucleic Acids as Potential Therapeutic Tools for Treatment of Bladder Carcinoma 2006 ·European Urology ·Susanne Fuessel, Axel Meye, Kai Kraemer, Doreen Kunze, Oliver W. Hakenberg, Manfred P. Wirth	9
5	Comparison of the Clinical Value of Complexed PSA and Total PSA in the Discrimination between Benign Prostatic Hyperplasia and Prostate Cancer 2006 ·Urologia Internationalis ·Michael Froehner, Oliver W. Hakenberg, Rainer Koch, U. Schmidt, Axel Meye, Manfred P. Wirth	12
6	Microarray analyses in bladder cancer cells: Inhibition of hTERT expression down‐regulates EGFR 2006 ·International Journal of Cancer ·Kai Kraemer, U. Schmidt, Susanne Fuessel, Alexander Herr, Manfred P. Wirth, Axel Meye	18
7	Vaccination of hormone‐refractory prostate cancer patients with peptide cocktail‐loaded dendritic cells: Results of a phase I clinical trial 2006 ·The Prostate ·Susanne Fuessel, Axel Meye, Marc Schmitz, Stefan Zastrow, C. Linné, K. Richter, (unknown), Oliver W. Hakenberg, (unknown), E. Peter Rieber, Manfred P. Wirth	100
8	Prognostic relevance of uPAR-del4/5 and TIMP-3 mRNA expression levels in breast cancer 2005 ·European Journal of Cancer ·Matthias Kotzsch, Juliane Farthmann, Axel Meye, Susanne Fuessel, Gustavo Baretton, Vivianne C. G. Tjan‐Heijnen, Manfred Schmitt, Thomas Luther, Fred C.G.J. Sweep, Viktor Magdolen, Paul N. Span	40
9	Transcript quantification of Dresden G protein-coupled receptor (D-GPCR) in primary prostate cancer tissue pairs 2005 ·Cancer Letters ·Susanne Fuessel, Bernd Weigle, U. Schmidt, Gustavo Baretton, Rainer Koch, Michael Bachmann, E. Peter Rieber, Manfred P. Wirth, Axel Meye	13
10	D‐PCa‐2: A novel transcript highly overexpressed in human prostate and prostate cancer 2004 ·International Journal of Cancer ·Bernd Weigle, Andrea Kießling, Reinhard Ebner, Susanne Fuessel, Achim Temme, Axel Meye, Marc Schmitz, Michael A. Rieger, D. Ockert, Manfred P. Wirth, E. Peter Rieber	5
11	Induction of proliferation and differentiation of cultured urothelial cells on acellular biomaterials 2004 ·British Journal of Urology ·(unknown), Axel Meye, Oliver W. Hakenberg, Michael Haase, Gustavo Baretton, Manfred P. Wirth	19
12	Reduced expression of hMSH2 protein is correlated to poor survival for soft tissue sarcoma patients 2003 ·Cancer ·Helge Täubert, Frank Bartel, Matthias Kappler, Katja Schuster, Axel Meye, Christine Lautenschläger, (unknown), Matthias Bache, Hannelore Schmidt, Hans‐Jürgen Holzhausen, Peter Würl	16
13	Tissue specific expression and serum levels of human tissue factor in patients with urological cancer 2003 ·Cancer Letters ·Yvonne Förster, Axel Meye, Sybille Albrecht, Matthias Kotzsch, S. Füssel, Manfred P. Wirth, Bernd Schwenzer	24
14	Prostate stem cell antigen: Identification of immunogenic peptides and assessment of reactive CD8⁺ T cells in prostate cancer patients 2002 ·International Journal of Cancer ·Andrea Kießling, Marc Schmitz, Stefan Stevanović, Bernd Weigle, Kristina Hölig, Monika Füssel, S. Füssel, Axel Meye, Manfred P. Wirth, Ernst Peter Rieber	61
15	A MboII polymorphism in exon 11 of the human MDM2 gene occuring in normal blood donors and in soft tissue sarcoma patients: an indication for an increased cancer susceptibility? 2000 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Helge Täubert, Matthias Kappler, Axel Meye, Frank Bartel, Thilo Schlott, Christine Lautenschläger, Matthias Bache, Hannelore Schmidt, Peter Würl	4
16	No p16INK4A/CDKN2/MTS1 mutations independent of p53 status in soft tissue sarcomas 1998 ·The Journal of Pathology ·Axel Meye, Peter Würl, Raoul Hinze, Dieter Berger, Matthias Bache, Hannelore Schmidt, (unknown), Helge Täubert	13
17	Significance of retinoblastoma and mdm2 gene expression as prognostic markers for soft-tissue sarcoma 1998 ·Langenbeck s Archives of Surgery ·Peter Würl, Axel Meye, Dieter Berger, Christine Lautenschläger, Matthias Bache, Hans-Jürgen Holzhausen, Hannelore Schmidt, Henning Dralle, (unknown), Helge Täubert	17
18	How is the mutational status for tumor suppressors p53 and p16INK4A in MFH of the bone? 1998 ·Cancer Letters ·Helge Täubert, Dieter Berger, Raoul Hinze, Axel Meye, Peter Würl, Pancras C.W. Hogendoorn, Hans-Jürgen Holzhausen, Hannelore Schmidt, (unknown)	6
19	p53 status in radiation-induced soft-tissue sarcomas 1998 ·Strahlentherapie und Onkologie ·Helge Täubert, Axel Meye, Matthias Bache, Raoul Hinze, Hans-Jürgen Holzhausen, Hannelore Schmidt, (unknown), (unknown), Peter Würl	4
20	Frequent occurrence of p53 mutations in rhabdomyosarcoma and leiomyosarcoma, but not in fibrosarcoma and malignant neural tumors 1996 ·International Journal of Cancer ·Peter Würl, Helge Täubert, Matthias Bache, Jens Krøll, Axel Meye, Dieter Berger, (unknown), Hans‐Jürgen Holzhausen, Raoul Hinze, Hannelore Schmidt, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact